HP
HarbourVest Partners LLC
13F filer · CIK 0001201001Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$170MU.S. long equity reported on 13F
Positions61 new · 0 closed
Net flow last quarter+$25.9MBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 20266 positions | |||||
| $102M | 59.79% | 1.33% | Not reported | Q3 2025 | |
| $29.1M | 17.09% | 1.34% | Not reported | Q1 2026 | |
| $25.9M | 15.24% | 0.72% | New | Q2 2026 | |
| $7.78M | 4.57% | Not reported | Not reported | Q1 2022 | |
| $5.56M | 3.27% | 2.45% | Not reported | Q4 2024 | |
| $71.1K | 0.04% | 0.02% | Not reported | Q4 2021 | |
| Q1 2026Reported May 15, 20265 positions | |||||
| $65.8M | 65.17% | 1.33% | Not reported | Q3 2025 | |
| $21.5M | 21.33% | 1.34% | New | Q1 2026 | |
| $7.95M | 7.88% | Not reported | Not reported | Q1 2022 | |
| $5.61M | 5.56% | 2.45% | Not reported | Q4 2024 | |
| $65.6K | 0.06% | 0.02% | Not reported | Q4 2021 | |
| Q4 2025Reported Feb 17, 20267 positions | |||||
| $145M | 83.38% | 1.33% | Not reported | Q3 2025 | |
| $10.3M | 5.90% | Not reported | Not reported | Q1 2022 | |
| $7.8M | 4.48% | 2.45% | Not reported | Q4 2024 | |
| $6.9M | 3.96% | Not reported | Not reported | Q4 2024 | |
| $3.9M | 2.24% | 2.78% | New | Q4 2025 | |
| RTRPTXRepare Therapeutics Inc. | $31.9K | 0.02% | 0.03% | Not reported | Q1 2021 |
| $28.9K | 0.02% | 0.03% | Not reported | Q4 2021 | |
| Q3 2025Reported Nov 14, 20259 positions | |||||
| $184M | 89.77% | Not reported | New | Q3 2025 | |
| $12.4M | 6.06% | Not reported | Not reported | Q1 2022 | |
| $3.82M | 1.86% | 2.71% | Not reported | Q4 2024 | |
| $3.34M | 1.63% | Not reported | New | Q3 2025 | |
| $708K | 0.35% | 0.00% | Not reported | Q4 2022 | |
| $370K | 0.18% | 0.00% | -73.0% | Q1 2021 | |
| SSONDSonder Holdings Inc. | $286K | 0.14% | 1.69% | Not reported | Q1 2022 |
| RTRPTXRepare Therapeutics Inc. | $21.6K | 0.01% | 0.03% | Not reported | Q1 2021 |
| $14.5K | 0.01% | 0.03% | Not reported | Q4 2021 | |
Premium opens every quarter this fund has filed